Healthcare Market Reports

Prevalence of autoimmune diseases has led to an upsurge in demand for plasmapheresis globally. Growing need for conducting an extracorporeal therapy is further expected to impact growth of the global autoimmune diseases market positively. Some of the autoimmune diseases that increasingly fuel demand for plasmapheresis include type 1 diabetes, celiac disease, rheumatoid arthritis, temporal arteritis and lupus. In a recently published report, CDC stated that 9.4% of the population in the U.S. have diabetes, and 30.3 million globally. Plasmapheresis is also used for treatment of various forms of neurotherapy and sickle cell diseases. According to FactMR, the global  Plasmapheresis Market  is expected to represent a value of over US$ 1,500 Mn by the end of 2026. Treatment of the Autoimmune Diseases to Boost Demand Increasing prevalence of various autoimmune diseases will continue to fuel demand for extracorporeal therapies globally. Occurrence of autoimmune disorders...

Growing prevalence of urological diseases has led to surge in demand for the urological treatments. In addition, increasing geriatric population is further expected to propel demand for various urological treatments globally. Kidney stone, urinary incontinence, bladder cancer, stress incontinence and hematuria are a few urological diseases that continue to impact growth of the global urology devices in the global market. According to FactMR, the global  Urology Devices Market  is expected to represent a value of over US$ 16,300 Mn by the end of 2026. Prevalence of Kidney Diseases to Boost Adoption Lack of water intake increasingly leads to prevalence of kidney stone among people of various age groups. Prevalence of urological diseases such as kidney stone can lead to painful urination, fever due to the infection in the urinary tract, vomiting and constant need to urinate. In addition, prevalence of bladder cancer has also led to surge in demand for minimally invasi...

Fibrosarcoma is cancer, which is a part of larger collection of cancers known as sarcomas. Fibrosarcoma is generally treated with the help of chemotherapy. Meanwhile, some fibrosarcoma is not treatable with chemotherapy, especially in the case where cancer has spread to the parts like liver. In order to treat such type of cancers, researchers are focusing on developing targeted therapies. These targeted therapies attempt to capitalize on the biological characteristic of a cancer cell to eradicate the tumor. This is the factor that will make targeted therapy more effective than the traditional treatments. There are two important reasons for the development of targeted therapy. One is that it targets only cancer cells and kills it, while normal cells can spread. Second is that it provides effective treatment with minimum side-effects. Pharmaceutical companies are also focusing on research and development of drugs that can be effective in the treatment of fibrosarcoma and other types of...